| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lachance Carrie | President and CEO, Director | C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS | /s/ Kevin Whitman, Attorney-in-Fact for Carrie Lachance | 25 Sep 2025 | 0001790024 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INFU | Common Stock | Award | $0 | +50,000 | +25% | $0.000000 | 251,849 | 23 Sep 2025 | Direct | F1 |
| transaction | INFU | Common Stock | Tax liability | $201,078 | -19,675 | -7.8% | $10.22 | 232,174 | 23 Sep 2025 | Direct | F2 |
| holding | INFU | Common Stock | 201,849 | 23 Sep 2025 | Direct |
| Id | Content |
|---|---|
| F1 | On September 23, 2025, 50,000 performance-based restricted stock units, granted on May 16, 2025, vested |
| F2 | Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of the common stock issued on May 16, 2025 |